132 related articles for article (PubMed ID: 7930468)
1. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma.
Martínez Cerezo FJ; Tomás A; Donoso L; Enríquez J; Guarner C; Balanzó J; Martínez Nogueras A; Vilardell F
J Hepatol; 1994 Jun; 20(6):702-6. PubMed ID: 7930468
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma.
Elba S; Giannuzzi V; Misciagna G; Manghisi OG
Ital J Gastroenterol; 1994 Mar; 26(2):66-8. PubMed ID: 8032079
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.
Riestra S; Rodriguez M; Delgado M; Suárez A; González N; de la Mata M; Diaz G; Miño-Fugarolas G; Rodrigo L
J Clin Gastroenterol; 1998 Apr; 26(3):200-3. PubMed ID: 9600369
[TBL] [Abstract][Full Text] [Related]
4. Controlled clinical trial of doxorubicin and tamoxifen versus tamoxifen monotherapy in hepatocellular carcinoma.
Schachschal G; Lochs H; Plauth M
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):281-4. PubMed ID: 10750647
[TBL] [Abstract][Full Text] [Related]
5. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.
Farinati F; De Maria N; Fornasiero A; Salvagnini M; Fagiuoli S; Chiaramonte M; Naccarato R
Dig Dis Sci; 1992 May; 37(5):659-62. PubMed ID: 1373360
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.
Castells A; Bruix J; Brú C; Ayuso C; Roca M; Boix L; Vilana R; Rodés J
Gastroenterology; 1995 Sep; 109(3):917-22. PubMed ID: 7657122
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
Chow PK
Cancer Treat Rev; 2005 Oct; 31(6):491-5. PubMed ID: 16214294
[No Abstract] [Full Text] [Related]
9. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.
Farinati F; Salvagnini M; de Maria N; Fornasiero A; Chiaramonte M; Rossaro L; Naccarato R
J Hepatol; 1990 Nov; 11(3):297-301. PubMed ID: 1705274
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme).
Lancet; 1998 Jul; 352(9121):17-20. PubMed ID: 9800740
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
14. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of tamoxifen in hepatocellular carcinoma.
Engstrom PF; Levin B; Moertel CG; Schutt A
Cancer; 1990 Jun; 65(12):2641-3. PubMed ID: 2160313
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.
Perrone F; Gallo C; Daniele B; Gaeta GB; Izzo F; Capuano G; Adinolfi LE; Mazzanti R; Farinati F; Elba S; Piai G; Calandra M; Stanzione M; Mattera D; Aiello A; De Sio I; Castiglione F; Russo M; Persico M; Felder M; Manghisi OG; De Maio E; Di Maio M; Pignata S;
Curr Pharm Des; 2002; 8(11):1013-9. PubMed ID: 11945148
[TBL] [Abstract][Full Text] [Related]
17. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC.
Pelletier G; Ducreux M; Gay F; Luboinski M; Hagège H; Dao T; Van Steenbergen W; Buffet C; Rougier P; Adler M; Pignon JP; Roche A
J Hepatol; 1998 Jul; 29(1):129-34. PubMed ID: 9696501
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial.
Manesis EK; Giannoulis G; Zoumboulis P; Vafiadou I; Hadziyannis SJ
Hepatology; 1995 Jun; 21(6):1535-42. PubMed ID: 7768497
[TBL] [Abstract][Full Text] [Related]
19. Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.
Nowak AK; Stockler MR; Chow PK; Findlay M
Cancer; 2005 Apr; 103(7):1408-14. PubMed ID: 15744746
[TBL] [Abstract][Full Text] [Related]
20. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
